Skip to content
Home
About us
Insights
Stocks
Compliance
Special Services
Contact
Language
EN
BR
EN
EN
BR
Tag:
pharmaceutical regulation
Insights
Anvisa Reviews Elevidys, a R$20 Million Gene Therapy Suspended in Brazil
29 de April de 2026
Nelson Mussolini
,
Opinion
When State Failure Becomes a Public Health Risk
31 de March de 2026
Insights
Brazil’s Anvisa Expands Medical Cannabis Rules, Allows Compounding Pharmacies
28 de January de 2026
